Dare Bioscience is a female-led women's health biotech company developing evidence-based solutions across contraception, sexual health, menopause, pelvic pain, fertility, vaginal health, and infectious disease. Its portfolio includes FDA-approved XACIATO (clindamycin vaginal gel for bacterial vaginosis), commercialized DARE to PLAY Sildenafil Cream, and pipeline candidates including Ovaprene (Phase 3 contraceptive), Sildenafil Cream 3.6% for FSAD, DARE-HRT1, and DARE-HPV. The company pursues FDA approval, Section 503B compounding, and consumer health product pathways.
Q2 FY2026 — expected 2026-09-13
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-26 | 2025-12-31 | 0001401914-26-000004 | EDGAR | 136K words |
| 2025-03-31 | 2024-12-31 | 0001401914-25-000012 | EDGAR | 132K words |
| 2024-03-28 | 2023-12-31 | 0001401914-24-000016 | EDGAR | 115K words |
| 2023-03-30 | 2022-12-31 | 0001401914-23-000013 | EDGAR | — |
| 2022-03-31 | 2021-12-31 | 0001401914-22-000032 | EDGAR | — |
| 2021-03-30 | 2020-12-31 | 0001401914-21-000041 | EDGAR | — |
| 2020-03-27 | 2019-12-31 | 0001401914-20-000042 | EDGAR | — |
| 2019-04-01 | 2018-12-31 | 0001401914-19-000015 | EDGAR | — |
| 2018-03-28 | 2017-12-31 | 0001564590-18-006989 | EDGAR | — |
| 2017-03-31 | 2016-12-31 | 0001564590-17-005798 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-13 | 2026-06-30 | 0001401914-26-000043 | EDGAR | 35K words |
| 2025-11-13 | 2025-09-30 | 0001401914-25-000050 | EDGAR | 32K words |
| 2025-08-14 | 2025-06-30 | 0001401914-25-000044 | EDGAR | 31K words |
| 2025-05-13 | 2025-03-31 | 0001401914-25-000022 | EDGAR | 30K words |
| 2024-11-14 | 2024-09-30 | 0001401914-24-000041 | EDGAR | 31K words |
| 2024-08-12 | 2024-06-30 | 0001401914-24-000038 | EDGAR | 27K words |
| 2024-05-14 | 2024-03-31 | 0001401914-24-000033 | EDGAR | 25K words |
| 2023-11-09 | 2023-09-30 | 0001401914-23-000048 | EDGAR | 29K words |
| 2023-08-10 | 2023-06-30 | 0001401914-23-000045 | EDGAR | 28K words |
| 2023-05-11 | 2023-03-31 | 0001401914-23-000023 | EDGAR | 22K words |
| 2022-11-10 | 2022-09-30 | 0001401914-22-000087 | EDGAR | — |
| 2022-08-09 | 2022-06-30 | 0001401914-22-000075 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-11 | 0001401914-26-000050 | EDGAR | 1K words |
| 2026-09-09 | 0001493152-26-041904 | EDGAR | 0K words |
| 2026-08-17 | 0001493152-26-038649 | EDGAR | 1K words |
| 2026-08-13 | 0001493152-26-037737 | EDGAR | 4K words |
| 2026-07-24 | 0001493152-26-034483 | EDGAR | 0K words |
| 2026-07-17 | 0001401914-26-000040 | EDGAR | 1K words |
| 2026-07-13 | 0001493152-26-032963 | EDGAR | 0K words |
| 2026-03-26 | 0001493152-26-012902 | EDGAR | 5K words |
| 2026-03-17 | 0001493152-26-010594 | EDGAR | 1K words |
| 2026-03-09 | 0001493152-26-009364 | EDGAR | 1K words |
315 total filings indexed. 283 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001401914 |
| Ticker | DARE |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.darebioscience.com |
| Listed | 2014-04-10 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/DARE (~200 tokens, structured JSON with cryptographic provenance)